Cipher Capital’s Evolent Health EVH Stock Holding History

Cipher Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-38,250	Closed	-$545K	–	521
2018 Q1	$545K	Buy	+38,250	New	+$548K	0.07%	391

Other funds holding EVH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Cipher Capital's EVH Position: Q2 2018 in Review

Cipher Capital sold out of Evolent Health (EVH) in Q2 2018, closing a stake of 38,250 shares — an estimated $545K sold.

Cipher Capital first reported a position in EVH in Q1 2018 and held it in 1 quarter. The position peaked at $545K in Q1 2018. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2018.

Cipher Capital reported no remaining Evolent Health position as of Q2 2018 after selling out during the quarter.
Cipher Capital sold 38,250 Evolent Health shares in Q2 2018, an estimated $545K.
Cipher Capital first reported a position in Evolent Health in Q1 2018 and held it in 1 quarter.
Cipher Capital's Evolent Health position peaked at $545K in Q1 2018.
178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2018.

Based on Cipher Capital's 13F filing for Q2 2018, filed 14 Aug 2018.